🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/06/2010 | 34,07 | 34,52 | 34,06 | 34,36 | -0,03% | 1,34% | 18.167.394 |
| 15/06/2010 | 33,47 | 34,40 | 33,43 | 34,37 | +2,86% | 2,91% | 22.954.658 |
| 14/06/2010 | 33,44 | 33,64 | 33,35 | 33,42 | +0,46% | 0,86% | 14.311.802 |
| 11/06/2010 | 32,78 | 33,49 | 32,66 | 33,26 | +0,61% | 2,53% | 18.989.865 |
| 10/06/2010 | 32,58 | 33,19 | 32,43 | 33,06 | +2,79% | 2,31% | 19.612.901 |
| 09/06/2010 | 32,31 | 32,57 | 31,96 | 32,17 | -0,30% | 1,89% | 13.463.761 |
| 08/06/2010 | 31,88 | 32,32 | 31,58 | 32,26 | +1,50% | 2,30% | 16.223.983 |
| 07/06/2010 | 31,67 | 31,98 | 31,58 | 31,78 | +0,42% | 1,27% | 14.809.288 |
| 04/06/2010 | 32,30 | 32,37 | 31,48 | 31,65 | -3,27% | 2,75% | 19.078.316 |
| 03/06/2010 | 32,85 | 32,98 | 32,43 | 32,72 | -0,20% | 1,66% | 13.739.385 |
| 02/06/2010 | 32,09 | 32,81 | 31,99 | 32,79 | +2,48% | 2,53% | 16.971.522 |
| 01/06/2010 | 31,90 | 32,46 | 31,78 | 31,99 | -0,47% | 2,12% | 21.756.061 |
| 28/05/2010 | 32,10 | 32,56 | 31,97 | 32,15 | +0,21% | 1,84% | 26.192.454 |
| 27/05/2010 | 31,41 | 32,13 | 31,28 | 32,08 | +3,70% | 2,70% | 32.049.098 |
| 26/05/2010 | 30,52 | 31,35 | 30,38 | 30,94 | +1,12% | 3,16% | 27.518.803 |
| 25/05/2010 | 29,87 | 30,61 | 29,68 | 30,59 | +0,63% | 3,13% | 21.679.766 |
| 24/05/2010 | 30,41 | 30,83 | 30,16 | 30,40 | -0,56% | 2,20% | 13.930.016 |
| 21/05/2010 | 29,77 | 30,68 | 29,62 | 30,57 | +0,69% | 3,56% | 26.721.694 |
| 20/05/2010 | 30,75 | 31,06 | 30,30 | 30,36 | -2,45% | 2,48% | 25.881.198 |
| 19/05/2010 | 30,73 | 31,39 | 30,60 | 31,13 | +0,83% | 2,58% | 22.192.134 |
| 18/05/2010 | 31,46 | 31,49 | 30,82 | 30,87 | -1,31% | 2,12% | 19.165.195 |
| 17/05/2010 | 31,41 | 31,55 | 30,71 | 31,28 | -0,30% | 2,67% | 16.146.222 |
| 14/05/2010 | 31,82 | 31,82 | 31,18 | 31,37 | -1,29% | 2,01% | 22.117.621 |
| 13/05/2010 | 32,14 | 32,20 | 31,59 | 31,78 | -0,98% | 1,90% | 15.354.353 |
| 12/05/2010 | 32,41 | 32,48 | 31,90 | 32,10 | +0,39% | 1,80% | 20.002.442 |
| 11/05/2010 | 31,82 | 32,55 | 31,52 | 31,98 | -2,16% | 3,24% | 25.819.786 |
| 10/05/2010 | 32,37 | 33,26 | 32,34 | 32,68 | +2,27% | 2,86% | 24.561.976 |
| 07/05/2010 | 32,36 | 32,65 | 31,44 | 31,96 | -2,28% | 3,75% | 27.703.775 |
| 06/05/2010 | 33,79 | 33,95 | 29,29 | 32,70 | -3,71% | 13,78% | 32.246.750 |
| 05/05/2010 | 33,80 | 34,13 | 33,30 | 33,96 | -0,61% | 2,46% | 22.489.661 |